Dr. J. (Jeroen) de Jonge is director of the liver machine perfusion program at the Erasmus MC Transplant Institute, Rotterdam – NL. Clinically over 90 cold (DHOPE) and warm (DHOPE-COR-NMP and aNRP) liver perfusions per year are performed, yielding excellent one-year graft survival and low post-transplant cholangiopathy in a case mix of 55% DCD donor livers.
His research portfolio involves clinical and translational research on in-situ and ex-situ machine perfusion to predict and ameliorate outcomes after liver transplantation. He participated in international studies on reduction of (biliary) complications after liver transplantation, including protocol-changing trials, such as the Dutch randomized trials on hypothermic oxygenated liver perfusion and transport oxygenated kidney perfusion. He is PI of the upcoming Dutch Ministry of Health sponsored randomized trial on ex-situ versus in-situ liver machine perfusion, starting 2026. Translational research is focusing on treatment strategies during machine perfusion, granted with Convergence, TKI-LSH and ZonMw funding. Active research collaborations include Cleveland Clinics (USA), UPENN (USA), University of Colorado (USA), Ghent (B) and Dresden (D).